Can MRIs ensure prostate cancer screenings do more good than harm?

Plus: FDA vows to crack down on regulating food additives

September 27, 2024 Check out STAT+

Sponsored By

JEFF PACHOUD/AFP via Getty Images Can MRIs ensure prostate cancer screening does more good than harm? A study finds that the harms of overdiagnosing prostate cancer is lessened when MRI is used as well as PSA tests. By Angus Chen STAT+ | The little-known Chinese biotech whose cancer drug beat Keytruda has global ambitions Little-known Chinese biotech Akeso partnered with Summit Therapeutics on a lung cancer immunotherapy that rivals Merck's Keytruda By Jonathan Wosen STAT+ | FDA introduces plan to assess safety of common chemicals added to food Many details remain unclear, such as which of the additives food companies use to enhance color, texture, and durability will be examined. By Lizzy Lawrence

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser